// App-Quantinova.ai

2639 : Incidence and Outcome In Adults With Acute Lymphoblastic Leukemia With Primary Central Nervous System Involvement

Researchers

Presenter

  • Muhamed Baljevic

Principal Investigators

  • Hagop M. Kantarjian

  • Deborah A. Thomas

  • Mark Brandt

  • Susan -Brien

  • Jorge Cortes

  • Michael Rytting

  • Jyothsna Dasarathula

  • Gautam Borthakur

  • Jan A. Burger

  • Farhad Ravandi

  • Elias Jabbour

  • Marina Konopleva

  • Sherry Pierce

Medical Centers

  • Department of Radiology, MD Anderson Cancer Center, Houston, TX

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Lymphoma, MD anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Divsion of Cancer Medicine, MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

  • Hypercarotenemia and vitamin A deficiency

Biomarkers

  • B-lymphocyte antigen CD20

  • Breakpoint Cluster Region

  • Ph chromosome

  • Human albumin

  • Cerebrospinal fluid

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Methotrexate

  • Vincristine

  • Doxorubicin

  • Cytarabine liposomal

  • Ponatinib

  • Rituximab

  • dasatinib

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved